Rmr Wealth Builders Cellectis S.A. Transaction History

Rmr Wealth Builders

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 16, 2021	SELL	$14.36 - $20.93 $29,222 - $42,592	-2,035 Closed	0 $0
Q4 2020 Feb 26, 2021	BUY	$15.87 - $31.64 $32,295 - $64,387	2,035 New	2,035 $55,000
Q3 2020 Nov 13, 2020	SELL	$15.7 - $20.84 $29,892 - $39,679	-1,904 Closed	0 $0
Q2 2020 Aug 19, 2020	BUY	$8.21 - $21.02 $4,926 - $12,612	600 Added 46.01%	1,904 $34,000
Q4 2019 Mar 03, 2020	BUY	$9.73 - $19.31 $12,687 - $25,180	1,304 New	1,304 $22,000

11.2M

2.8K

17.9K

Ticker CLLS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 45,510,800
Market Cap $86M
Description
Cellectis S.A., a clinical stage biotechnological company, develops immuno-oncology products based on gene-edited T-cells that express chimeric antigen receptors to target and eradicate cancer cells. It operates through two segments, Therapeutics and Plants. The company is developing UCART19, an allogeneic T-cell product candidate for the treatm...

Get notified when there are updates to the investment portfolio of Rmr Wealth Builders, based on Form 13F filings with the SEC.

Stay updated on Rmr Wealth Builders with notifications on news.